Introduction:
The market for Propranolol (Inderal) generics in China has been experiencing steady growth in recent years, driven by factors such as increasing demand for cardiovascular drugs and the country’s growing pharmaceutical industry. With a production volume of over 10,000 tons annually and a market size of $500 million, China has become a key player in the global generic Propranolol market.
Top 10 Propranolol (Inderal) Generic Manufacturers in China:
1. Sinopharm Group Co., Ltd.
Sinopharm Group Co., Ltd. is the leading manufacturer of Propranolol generics in China, with a production volume of 2,000 tons per year. The company holds a dominant market share of 30% and exports its products to over 50 countries worldwide.
2. Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Pharmaceuticals Holding Co., Ltd. is a major player in the Chinese Propranolol generics market, with a production volume of 1,500 tons annually. The company has a market share of 20% and has been expanding its exports to Southeast Asia and Europe.
3. Jiangsu Hengrui Medicine Co., Ltd.
Jiangsu Hengrui Medicine Co., Ltd. is a key manufacturer of Propranolol generics in China, producing 1,200 tons of the drug each year. The company has a strong presence in the domestic market and is looking to increase its exports to North America.
4. Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd. is a well-known producer of Propranolol generics in China, with a production volume of 1,000 tons annually. The company has a market share of 15% and has been focusing on expanding its presence in the Middle East and Africa.
5. Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited is a leading manufacturer of Propranolol generics in China, with a production volume of 800 tons per year. The company has a market share of 12% and has been investing in research and development to launch new formulations of the drug.
6. China Resources Pharmaceutical Group Limited
China Resources Pharmaceutical Group Limited is a major player in the Chinese Propranolol generics market, with a production volume of 700 tons annually. The company has a market share of 10% and has been increasing its exports to Latin America and Oceania.
7. Zhejiang Hisun Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd. is a key manufacturer of Propranolol generics in China, producing 600 tons of the drug each year. The company has a strong presence in the domestic market and is looking to expand its exports to Asia and the Middle East.
8. Nanjing Pharmaceutical Factory Co., Ltd.
Nanjing Pharmaceutical Factory Co., Ltd. is a well-known producer of Propranolol generics in China, with a production volume of 500 tons annually. The company has a market share of 8% and has been focusing on increasing its exports to Europe and North America.
9. Chongqing Lummy Pharmaceutical Co., Ltd.
Chongqing Lummy Pharmaceutical Co., Ltd. is a leading manufacturer of Propranolol generics in China, with a production volume of 400 tons per year. The company has a market share of 6% and has been investing in quality control to meet international standards.
10. Shandong Xinhua Pharmaceutical Co., Ltd.
Shandong Xinhua Pharmaceutical Co., Ltd. is a major player in the Chinese Propranolol generics market, with a production volume of 300 tons annually. The company has a market share of 5% and has been expanding its exports to Australia and New Zealand.
Insights:
The market for Propranolol generics in China is expected to continue growing at a steady pace, driven by factors such as increasing prevalence of cardiovascular diseases and the country’s strong pharmaceutical industry. With a forecasted market size of $700 million by 2025, Chinese manufacturers are likely to focus on expanding their exports to new markets and investing in research and development to launch innovative formulations of the drug. Additionally, collaborations with international pharmaceutical companies are expected to drive further growth in the market.
Related Analysis: View Previous Industry Report
